显著的表型组和相关的临床结果在患有多变性心肌病的患者
Soongu Kwak1,2, Jihoon Kim3, Chan-Soon Park1,2
1Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea.
Journal of the American Heart Association
|October 11, 2024
概括
这项研究确定了三种不同的高性心肌病 (HCM) 患者群体,每个患者都有独特的突然心脏死亡 (SCD) 风险和不同的结果. 数据驱动的表型化有助于更好的风险分层和HCM患者管理.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 增高性心肌病变 (HCM) 是一种复杂的遗传性心脏病,具有可变的临床结果.
- 心脏突然死亡 (SCD) 是HCM患者的一个重大风险.
- 识别不同的患者表型对于准确的风险分层至关重要.
研究的目的:
- 在患有HCM的患者中识别不同的临床表型.
- 分析这些表型与SCD风险因素之间的关系.
- 检查与每个表型相关的临床特征和结果.
主要方法:
- 对来自两个三级医院的1231名HCM患者的回顾性分析.
- 隐性类别分析用于将患者分类为表型组.
- 评估临床结果的中位数是6.5年的随访时间.
主要成果:
- 确定了三种不同的HCM表型.
- 第二组 (具有高SCD风险因素的年轻患者) 显示了SCD相关事件的最高率 (在5年内8.2%).
- 第三组 (老年患者) 的全因和非心血管死亡率最高.
结论:
- 在HCM中,不同的临床表型与不同的SCD风险和结果有关.
- 数据驱动的表型化为HCM患者提供了有效的风险分层.
- 现型识别可以优化患者管理策略.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy I: Introduction and Classification
2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3


